Skip to Content


In the US, Dexrazoxane (dexrazoxane systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Cardiomyopathy Prophylaxis and Extravasation.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category


Chemical Names

(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione (WHO)

(S)-4,4'-(Propan-1,2-diyl)bis(piperazin-2,6-dion) (IUPAC)

Foreign Names

  • Dexrazoxanum (Latin)
  • Dexrazoxan (German)
  • Dexrazoxane (French)
  • Dexrazoxane (Spanish)

Generic Names

Brand Names

  • Ao Nuo Xian
    AosaiKang Pharmaceutical, China
  • Cardioxane
    Chiron, Egypt; Chiron, Slovakia; Medicamenta Ecuatoriana, Ecuador; Nolver, Venezuela; Novartis, Czech Republic; Novartis, Greece; Novartis, Lebanon; Novartis, Lithuania; Novartis, Poland; Novartis, Portugal
  • Cyrdanax
    Pharmaselect, Poland
  • Dexrazoxane
    Raffo, Argentina
  • Razoxane Tecnofarma
    Tecnofarma, Colombia
  • Savene
    SpePharm, Portugal; TopoTarget, Greece; SpePharm, Lithuania; Kissei Pharmaceutical, Japan
  • Zinecard
    Pfizer, Canada; Pharmacia & Upjohn, United States
  • Cardioxane
    Asofarma, Mexico; Clinigen, United Kingdom; Grupo Novartis, Spain; Novartis, Ireland; Novartis, Israel; Novartis, Netherlands; Novartis Farma, Italy
  • Cyrdanax
    Pharmaselect, Austria
  • Dexarazoxane Martian
    LKM, Argentina
  • Savene
    Clinigen, United Kingdom; Ferrer Farma, Spain; Norgine, Germany; SpePharm, Austria; SpePharm, Denmark; SpePharm, Ireland; SpePharm, Netherlands; SpePharm itala, Italy; Topotarget, Belgium

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.